JP2023528801A5 - - Google Patents
Info
- Publication number
- JP2023528801A5 JP2023528801A5 JP2022573159A JP2022573159A JP2023528801A5 JP 2023528801 A5 JP2023528801 A5 JP 2023528801A5 JP 2022573159 A JP2022573159 A JP 2022573159A JP 2022573159 A JP2022573159 A JP 2022573159A JP 2023528801 A5 JP2023528801 A5 JP 2023528801A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- promoter
- retinal
- raav
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032206P | 2020-05-29 | 2020-05-29 | |
| US63/032,206 | 2020-05-29 | ||
| US202163187154P | 2021-05-11 | 2021-05-11 | |
| US63/187,154 | 2021-05-11 | ||
| PCT/US2021/034624 WO2021243085A2 (en) | 2020-05-29 | 2021-05-27 | Adeno-associated virus virions with variant capsids and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528801A JP2023528801A (ja) | 2023-07-06 |
| JP2023528801A5 true JP2023528801A5 (enExample) | 2024-05-29 |
Family
ID=78706867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573159A Pending JP2023528801A (ja) | 2020-05-29 | 2021-05-27 | バリアントキャプシドを有するアデノ随伴ウイルスビリオン及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12031147B2 (enExample) |
| EP (1) | EP4157299A4 (enExample) |
| JP (1) | JP2023528801A (enExample) |
| KR (1) | KR20230043794A (enExample) |
| CN (1) | CN116249772A (enExample) |
| AU (1) | AU2021280317A1 (enExample) |
| CA (1) | CA3179597A1 (enExample) |
| MX (1) | MX2022015048A (enExample) |
| WO (1) | WO2021243085A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021378270A1 (en) * | 2020-11-10 | 2023-06-15 | Avirmax Biopharma Inc. | Engineered viral capsids and methods of use |
| WO2022150776A1 (en) | 2021-01-11 | 2022-07-14 | Vedere Bio Ii, Inc. | OPTOGENETIC COMPOSITIONS COMPRISING A CBh PROMOTER SEQUENCE AND METHODS FOR USE |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス，インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| CN118791624B (zh) * | 2023-04-11 | 2026-04-03 | 苏州星明优健生物技术有限公司 | 用于治疗视网膜神经退行性疾病的新型gpcr嵌合视蛋白 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026052039A1 (en) * | 2024-09-06 | 2026-03-12 | Sichuan Real & Best Biotech Co., Ltd. | Engineered adeno-associated virus capsid protein and the use thereof |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| CN118955654B (zh) * | 2024-10-15 | 2025-05-16 | 朗信启昇(苏州)生物制药有限公司 | 具有变异衣壳的腺相关病毒病毒体及其用途 |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663624B2 (en) * | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| DK3693025T3 (da) | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| FI3265178T3 (fi) * | 2015-03-02 | 2026-08-03 | Adverum Biotechnologies Inc | Koostumuksia ja menetelmiä polynukleotidien viemiseksi intravitreaalisesti retinaalisiin tappisoluihin |
| JP6836999B2 (ja) | 2015-03-24 | 2021-03-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | アデノ随伴ウイルス変異体及びその使用方法 |
| WO2017197355A2 (en) * | 2016-05-13 | 2017-11-16 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| CN109640949B (zh) | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| AU2017345470B2 (en) * | 2016-10-19 | 2023-08-03 | Adverum Biotechnologies, Inc. | Modified AAV capsids and uses thereof |
| WO2018134168A1 (en) * | 2017-01-17 | 2018-07-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of expressing a polynucleotide of interest in the cone photoreceptors |
| KR20250023600A (ko) * | 2017-06-30 | 2025-02-18 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법 |
| MX2020001997A (es) * | 2017-08-28 | 2020-07-20 | Univ California | Variantes de capside de virus adenoasociado y metodos de uso de estas. |
| US20230049217A1 (en) * | 2021-05-21 | 2023-02-16 | Novartis Ag | Compositions and methods for enhancing visual function |
-
2021
- 2021-05-27 WO PCT/US2021/034624 patent/WO2021243085A2/en not_active Ceased
- 2021-05-27 AU AU2021280317A patent/AU2021280317A1/en not_active Abandoned
- 2021-05-27 EP EP21812280.2A patent/EP4157299A4/en not_active Withdrawn
- 2021-05-27 US US17/332,855 patent/US12031147B2/en active Active
- 2021-05-27 JP JP2022573159A patent/JP2023528801A/ja active Pending
- 2021-05-27 MX MX2022015048A patent/MX2022015048A/es unknown
- 2021-05-27 CN CN202180041153.9A patent/CN116249772A/zh active Pending
- 2021-05-27 CA CA3179597A patent/CA3179597A1/en active Pending
- 2021-05-27 KR KR1020227045801A patent/KR20230043794A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7706582B2 (ja) | 変異カプシドを有するアデノ随伴ウイルスビリオン及びその使用方法 | |
| JP2022125201A (ja) | 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法 | |
| JP2023126919A5 (enExample) | ||
| JP2020028308A5 (enExample) | ||
| JP2021522842A (ja) | 肝臓を標的とするアデノ随伴ウイルスベクター | |
| JP2021503914A5 (enExample) | ||
| JP2020528734A (ja) | バリアントカプシドを有するアデノ随伴ウイルスビリオン及びその使用方法 | |
| CN104087591A (zh) | 用于基因治疗的修饰的因子viii和因子ix基因和载体 | |
| JP2018515096A (ja) | 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むａａｖ分離株及び融合タンパク質 | |
| JP2022523679A (ja) | 体液性免疫を回避する組成物および方法 | |
| KR20230043794A (ko) | 변이체 캡시드를 갖는 아데노-연관 바이러스 비리온 및 이의 사용 방법 | |
| US20130090375A1 (en) | Virus-mediated delivery of bevacizumab for therapeutic applications | |
| JP7685070B2 (ja) | 血管新生に関連する眼疾患の処置のための組成物および方法 | |
| KR20230152008A (ko) | 단백질 m 유사체 및 융합 단백질 및 이들의 항체 기능 억제 용도 | |
| KR20260016939A (ko) | 아데노 부속 바이러스 캡시드 단백질, 이를 포함하는 아데노 부속 바이러스, 벡터 및 응용 | |
| WO2023198050A1 (zh) | 一种融合型腺相关病毒及其应用 | |
| WO2022222869A1 (zh) | 重组腺相关病毒及其应用 | |
| US20240092885A1 (en) | Vector constructs for delivery of nucleic acids encoding therapeutic anti-tnf antibodies and methods of using the same | |
| US20190330308A1 (en) | Modified soluble vegf receptor-1 genes and vectors for gene therapy | |
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| CN119264217A (zh) | 具有变异衣壳蛋白的腺相关病毒及其应用 | |
| HK40097868A (en) | Compositions and methods for treatment of ocular disease associated with angiogenesis | |
| CN116568815A (zh) | 用于基因疗法的眼部递送的腺相关病毒 | |
| RU2021101475A (ru) | Вирионы аденоассоциированного вируса с вариантным капсидом и способы их использования | |
| HK40048077B (en) | Synthetic liver-tropic adeno-associated virus capsids and uses thereof |